Article

A novel artificial lung organoid for simulating a patient derived adenocarcinoma of lung for personalized oncology

2021-04-27

Abstract excerpt

<h4>ABSTRACT</h4> Optimizing patient care based on precision oncology will inevitably become the standard of care. If we accept the principle that every persons’ cancer is different then the most effective therapies will have to be designed for the individual patient and for their tumors genetic profile. Access to tumor mutational profiling is now widely available but continues to be limited by cost and actionable...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e40a46d2-5b9b-5e74-a304-821d2fc7e01b
DOI: 10.1101/2021.04.20.21255803

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel artificial lung organoid for simulating a patient derived adenocarcinoma of lung for personalized oncologyDOI 10.1101/2021.04.20.21255803Read

Human Lung Adenocarcinoma-Derived Organoid Models for Drug ScreeningSemantic proximity Read

<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineSemantic proximity Read

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screeningSemantic proximity Read

Lung tumoroids as a testing platform for precision CAR T-cell therapySemantic proximity Read

Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapySemantic proximity Read

Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugsSemantic proximity Read

Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platformSemantic proximity Read

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patientsSemantic proximity Read

An optimized method to culture human primary lung tumor cell spheroidsSemantic proximity Read

Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platformSemantic proximity Read

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a weekSemantic proximity Read

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test.Semantic proximity Read